Terumo Neuro

admin2252025-09-06 20:32:00

About Terumo Neuro

Terumo Neuro, formerly known as MicroVention, Inc., is a wholly-owned subsidiary of Terumo Corporation. Founded in 1997 and headquartered in Aliso Viejo, California, it was rebranded as Terumo Neuro in September 2024 to better reflect its strategic positioning within the Terumo Group and its global presence in the neurovascular intervention field.

Core Business & Key Products

Terumo Neuro specializes in developing neurovascular medical devices with a comprehensive product portfolio for treating both hemorrhagic and ischemic strokes. Its key products include:

WEB™ Embolization System: An intrasaccular device for treating brain aneurysms by promoting thrombosis within the aneurysm sac.
FRED™ X Flow Diverter: A next-generation flow diverter with a unique double-layer micro-mesh design, offering improved radial support and flexibility for treating complex aneurysms.
LVIS™ EVO™ Coil-Assist Stent: A stent designed to provide support during aneurysm coiling, featuring enhanced visibility and precise placement.
SOFIA™ Flow 88 Aspiration Catheter: A large-bore aspiration catheter with tapered design and improved inner diameter for stronger aspiration power and safer acute ischemic stroke treatment.
Headway® Microcatheter Series: High-performance microcatheters for delivering embolization devices into small and tortuous vessels.

Technology Highlights

Terumo Neuro's technology innovations focus on improving treatment efficacy and patient outcomes:

Hydrogel-Coated Coils: Coils with hydrogel threads increase embolization density and reduce recurrence rates.
Double-Layer Micro-Mesh Stent Design: Captures plaque debris, reduces thrombosis risk, and optimizes hemodynamic performance.
Nitinol Braid Reinforcement: Enhances aspiration catheter durability and maintains lumen integrity during procedures.

Market Position & Global Presence

Terumo Neuro is a global leader in neurovascular interventions, with products available in over 80 countries. Its robust R&D capabilities and close collaboration with physicians have driven continuous innovation. Products like the WEB™ Embolization System and SOFIA™ Flow 88 have gained significant market recognition. Terumo Neuro actively participates in global exhibitions and academic conferences to showcase its latest technologies and further expand its market influence.